By Nick Paul Taylor - Fierce Biotech - The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back into American patients. Officials said...

By Alex (Guangyao) Xu - The Japan Times - In a quiet operating room on Kyoto University’s medical campus, a team of researchers slipped a syringe of lab-grown neurons into the brain of a living person. Leading the trial was Jun Takahashi, a neurosurgeon with the kind...

By Christina Elston - Cedars Sinai - Cedars-Sinai’s Lifelike Laboratory Model Is a New Way for Investigators to Study Motor Neurons That Die in Patients With the Neurodegenerative Illness Using stem cells from patients with ALS (amyotrophic lateral sclerosis),...

by Marisa Wexler - Multiple Sclerosis News Today - A CAR T-cell therapy from Iaso Biotherapeutics was tolerated well and led to marked improvements in disability for three people with progressive forms of multiple sclerosis (MS), according to early data from a Phase 1...

By Eleanor Garth - Longevity.Technology - Leopoldina issues policy paper urging integration of geroscience into national healthcare and research infrastructure. Germany’s National Academy of Sciences Leopoldina has published a detailed policy paper calling for a...

By Gina Kolata - New York Times - Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. A single infusion of a stem cell-based treatment may have cured 10...

By Stanford Report - Stanford researchers have developed a faster, more precise way to model and print vascular systems, solving a critical challenge in fabricating transplantable organs from patients’ own cells. There are more than 100,000 people on organ transplant...

By Sant Pau Research Institute - SciTechDaily - A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for future heart disease therapies. An international team of researchers has uncovered how...

By Antonio Pequeño IV - Forbes - Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir) will become...

by Harvard University - Microglia are a specialized type of immune cell that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that...

By Mass General Brigham - Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass General Cancer Center, is senior author and Stefanie Bailey, PhD, Hana Takei, and Giulia Escobar, PhD of the Krantz...

by Kermit Pattison - The Harvard Gazette - Decades later, Doug Melton and team are testing treatment that could make insulin shots obsolete. Doug Melton’s life irrevocably changed the day his child was diagnosed with a life-threatening disease. But unlike most other...